Filociclovir (cyclopropavir, MBX-400) is an antiviral drug which was developed for the treatment of cytomegalovirus infection and also shows some activity against other double-stranded DNA viruses.

It has reached Phase II human clinical trials.

[1][2][3] This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.